A retrospective study of impact of Covid-19 (Pfizer-BioNTech BNT162b2) vaccination during the third trimester of pregnancy on maternal and neonatal outcomes
Latest Information Update: 30 Sep 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 30 Sep 2021 New trial record
- 23 Sep 2021 Primary endpoint (composite adverse maternal outcomes) has not been met, according to Results published in the BJOG: An International Journal of Obstetrics and Gynaecology.
- 23 Sep 2021 Results published in the BJOG: An International Journal of Obstetrics and Gynaecology